A novel score for evaluating cerebral aneurysms treated with flow diversion: 4F-flow diversion predictive score

Author:

Kang Huibin1,Luo Bin1,Liu Jian1,Wang Anxin2,Zhang Hongqi3,Li Tianxiao4,Song Donglei5,Zhao Yuanli6,Guan Sheng7,Wang Yunyan8,Feng Wenfeng9,Wang Yang10,Shi Huaizhang11,Liu Jianmin12,Yang Xinjian13ORCID

Affiliation:

1. Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

2. Beijing Tiantan Hospital, Capital Medical University, Beijing, China

3. Xuanwu Hospital, Capital Medical University, Beijing, China

4. Zhengzhou University People’s Hospital, Zhengzhou, China

5. Shanghai Donglei Brain Hospital, Fudan University, Shanghai, China

6. Peking University International Hospital, Beijing, China

7. First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

8. Qilu Hospital of Shandong University, Jinan, China

9. Nanfang Hospital, Southern Medical University, Guangzhou, China

10. First Affiliated Hospital of Nanchang University, Nanchang, China

11. First Affiliated Hospital of Harbin Medical University, Harbin, China

12. Changhai Hospital Affiliated to Naval Medical University, Shanghai, China

13. Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, No.119 South Fourth Ring West Road, Fengtai District, Beijing 100050, China

Abstract

Background and purpose: Although grading scales for angiography outcomes following cerebral aneurysm treatment with flow diversion have been published, physicians have not widely adopted these scales in practice. The aim of this study is to propose and validate a novel Flow diversion Predictive Score (4F-FPS) grading scale based on previously established scales that is simple and reliable. Methods: We retrospectively analyzed consecutive patients who underwent endovascular treatment for cerebral aneurysms with flow diversion between January 2014 and September 2019. The included patients were randomly divided into the derivation and validation group in a 70/30 ratio, respectively. Aneurysms were classified as incomplete or complete occlusion based on final angiography outcomes. 4F-FPS was derived to predict aneurysm occlusion from multivariate logistic regression analyses in the derivation group and validated with previously published grading scales in the validation group. Results: Overall, 662 patients [mean age, 53.8 years; 72.5% (480/662) female] with 662 aneurysms treated with the PipelineTM flow diverter were included [69.9% (463/662) derivation group, 30.1% (199/662) validation group]. The incidence of aneurysm occlusion was 82.7%. 4F-FPS demonstrated significant discrimination in 10-fold cross validation [mean receiver operating characteristic (ROC) area, 0.862 ± 0.055] and calibration (Cox & Snell R2, 0.251; Nagelkerke R2, 0.413) in the derivation group. The ROC area of 4F-FPS score in both the derivation and validation groups is the largest compared with previously published grading scales/scores ( p < 0.05), which shows better sensitivity and specificity. The 4F-FPS score showed excellent prediction, discrimination, and calibration properties. Conclusion: The 4F-FPS score is a simple and reliable tool to predict angiography outcome after flow diversion treatment. If widely adopted, it may provide a common language to be used in future reporting of flow diversion results for clinical trials and daily practice. Clinical trial registration: http://www.clinicaltrials.gov . Unique identifier: NCT03831672

Funder

the National Key Research and Development Plan of China

the National Natural Science Foundation of China

the Special Research Project for Capital Health Development

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology,Pharmacology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3